Tag:
ALN-PCS
Latest Headlines
Latest Headlines
Alnylam scores efficacy data with PCSK9 drug
The data show that the small company has a horse in the race to advance PCSK9-targeting drugs as a brand new category of treatments for lowering LDL cholesterol.
Countering skeptics, Alnylam claims pioneering first in RNAi cholesterol study
Facing off against some deep-seated skepticism about the future of RNAi drug development, Alnylam ( $ALNY ) has pushed out a preliminary assessment of a small Phase I study demonstrating some dramatic
